ALIGN TECHNOLOGY,
INC.
|
(Exact
Name of Registrant as Specified in Its
Charter)
|
Delaware
|
(State
or Other Jurisdiction of
Incorporation)
|
0-32259
|
94-3267295
|
|
(Commission
File Number)
|
(IRS
Employer Identification
No.)
|
881
Martin Avenue, Santa Clara, California
|
95050
|
|
(Address
of Principal Executive Offices)
|
(Zip
Code)
|
(408)
470-1000
|
(Registrant’s
Telephone Number, Including Area
Code)
|
Not
applicable
|
(Former
Name or Former Address, if Changed Since Last
Report)
|
Exhibit
No.
|
Description
|
99.1
|
Press
Release of Align Technology, Inc. dated April 23,
2009
|
Dated: April
23, 2009
|
ALIGN
TECHNOLOGY, INC.
|
|
By:
|
/s/Kenneth B. Arola
|
|
Kenneth
B. Arola
|
||
Vice
President, Finance and Chief Financial
Officer
|
Exhibit
No.
|
Description
|
99.1
|
Press
Release of Align Technology, Inc. dated April 23,
2009
|
|
|
Investor Relations Contact
|
Press Contact
|
Shirley
Stacy
|
Shannon
Mangum Henderson
|
Align
Technology, Inc.
|
Ethos
Communication, Inc.
|
(408)
470-1150
|
(678)
540-9222
|
sstacy@aligntech.com
|
align@ethoscommunication.com
|
|
·
|
Net
revenues of $70.1 million, compared to outlook of $65.0 to $69.0
million
|
|
·
|
Case
shipments of 50.1 thousand, compared to outlook of 44.5 to 47.0
thousand
|
|
·
|
GAAP
diluted EPS of $0.04, compared to outlook of ($0.04) to
$0.00
|
Key
GAAP Operating Results
|
Q1 09 | Q4 08 | Q1 08 | |||||||||
Gross
Margin
|
75.2 | % | 72.7 | % | 73.8 | % | ||||||
Operating
Expense
|
$ | 47.4M | $ | 52.6M | $ | 50.5M | ||||||
Operating
Margin
|
7.5 | % | 1.8 | % | 6.2 | % | ||||||
Net
Profit
|
$ | 2.6M | $ | 65.5M | $ | 5.3M | ||||||
Earnings
Per Diluted Share (EPS)
|
$ | 0.04 | $ | 0.98 | $ | 0.07 | ||||||
Key
Non-GAAP Operating Results
|
Q1 09 | Q4 08 | Q1 08 | |||||||||
Non-GAAP
Operating Expense
|
$ | 46.5M | $ | 48.5M | $ | 50.5M | ||||||
Non-GAAP
Operating Margin
|
8.8 | % | 7.2 | % | 6.2 | % | ||||||
Non-GAAP
Net Profit
|
$ | 3.2M | $ | 4.9M | $ | 5.3M | ||||||
Non-GAAP
Earnings Per Diluted Share (EPS)
|
$ | 0.05 | $ | 0.07 | $ | 0.07 |
Revenue by Channel ($M):
|
Q1 09
|
% of Revenue
|
Q1 09/Q1 08
% Change
|
|||||||||
North
American Orthodontists
|
$ | 21.1 | 30.1 | % | (6.5 | )% | ||||||
North
American GP Dentists
|
$ | 30.9 | 44.1 | % | (8.9 | )% | ||||||
International
|
$ | 14.3 | 20.3 | % | 0.5 | % | ||||||
Non-case
Revenue*
|
$ | 3.8 | 5.5 | % | (5.7 | )% | ||||||
Total
Revenue
|
$ | 70.1 | 100.0 | % | (6.2 | )% | ||||||
*includes
training, ancillary products, and retainers
|
Cases Shipped by Channel:
|
Q1 09
|
% of Cases
|
Q1 09/Q1 08
% Change
|
|||||||||
North
American Orthodontists
|
16,890 | 33.7 | % | (4.0 | )% | |||||||
North
American GP Dentists
|
23,335 | 46.6 | % | (9.7 | )% | |||||||
International
|
9,835 | 19.7 | % | 18.1 | % | |||||||
Total
Cases Shipped
|
50,060 | 100.0 | % | (3.3 | )% |
Cases Shipped by Product:
|
Q1 09
|
% of Cases
|
Q1 09/Q1 08
% Change
|
|||||||||
Invisalign
Full
|
37,245 | 74.4 | % | (14.6 | )% | |||||||
Invisalign
Express
|
8,010 | 16.0 | % | (1.9 | )% | |||||||
Invisalign
Teen
|
3,895 | 7.8 | % | N/A | ||||||||
Invisalign
Assist
|
910 | 1.8 | % | N/A | ||||||||
Total
Cases Shipped
|
50,060 | 100.0 | % | (3.3 | )% | |||||||
Average
Selling Price (ASP), as billed:
|
Q1 09
|
|||||||||||
Total
Worldwide Blended ASP
|
$ | 1,365 | ||||||||||
International
ASP
|
$ | 1,450 | ||||||||||
Number
of Doctors Cases were Shipped to:
|
Q1 09
|
|||||||||||
North
American Orthodontists
|
3,670 | |||||||||||
North
American GP Dentists
|
10,625 | |||||||||||
International
|
3,070 | |||||||||||
Total
Doctors Cases were Shipped to Worldwide
|
17,365 | |||||||||||
Number
of Doctors Trained Worldwide:
|
Q1 09
|
Cumulative
|
||||||||||
North
American Orthodontists
|
75 | 8,740 | ||||||||||
North
American GP Dentists
|
815 | 33,475 | ||||||||||
International
|
330 | 14,515 | ||||||||||
Total
Doctors Trained Worldwide
|
1,220 | 56,730 | ||||||||||
Doctor
Utilization Rates*:
|
Q1 09
|
Q4 08
|
Q1 08
|
|||||||||
North
American Orthodontists
|
4.6 | 4.6 | 4.8 | |||||||||
North
American GP Dentists
|
2.2 | 2.3 | 2.4 | |||||||||
International
|
3.2 | 3.4 | 3.2 | |||||||||
Total
Utilization Rate
|
2.9 | 3.0 | 3.1 |
Total
Invisalign Patients (cases shipped):
|
Q1 09
|
Cumulative
|
||||||
Number
of Patients Treated or in Treatment (cases)
|
50,060 | 994,115 |
Three Months Ended
|
||||||||
|
March 31,
2009
|
March 31,
2008
|
||||||
Net
revenues
|
$ | 70,132 | $ | 74,776 | ||||
Cost
of revenues
|
17,425 | 19,608 | ||||||
Gross
profit
|
52,707 | 55,168 | ||||||
Operating
expenses:
|
||||||||
Sales
and marketing
|
27,854 | 28,059 | ||||||
General
and administrative
|
13,468 | 15,188 | ||||||
Research
and development
|
5,191 | 7,295 | ||||||
Restructuring
|
910 | - | ||||||
Total
operating expenses
|
47,423 | 50,542 | ||||||
Profit
from operations
|
5,284 | 4,626 | ||||||
Interest
and other income (expense), net
|
148 | 966 | ||||||
Profit
before income taxes
|
5,432 | 5,592 | ||||||
Provision
for income taxes
|
(2,796 | ) | (288 | ) | ||||
Net
profit
|
$ | 2,636 | $ | 5,304 | ||||
Net
profit per share
|
||||||||
-
basic
|
$ | 0.04 | $ | 0.08 | ||||
-
diluted
|
$ | 0.04 | $ | 0.07 | ||||
Shares
used in computing net profit per share
|
||||||||
-
basic
|
65,983 | 69,053 | ||||||
-
diluted
|
66,447 | 70,860 |
ALIGN
TECHNOLOGY, INC.
|
UNAUDITED
CONDENSED CONSOLIDATED BALANCE SHEETS
|
(in
thousands)
|
March
31,
2009
|
December
31,
2008
|
|||||||
ASSETS
|
||||||||
Current
assets:
|
||||||||
Cash
and cash equivalents
|
$ | 97,051 | $ | 87,100 | ||||
Marketable
securities, short-term
|
27,633 | 23,066 | ||||||
Accounts
receivable, net
|
51,665 | 52,362 | ||||||
Inventories,
net
|
2,068 | 1,965 | ||||||
Other
current assets
|
14,588 | 13,414 | ||||||
Total
current assets
|
193,005 | 177,907 | ||||||
Property
and equipment, net
|
26,000 | 26,979 | ||||||
Goodwill
and intangible assets, net
|
7,566 | 8,266 | ||||||
Deferred
tax asset
|
61,133 | 61,696 | ||||||
Other
long-term assets
|
1,573 | 4,493 | ||||||
Total
assets
|
$ | 289,277 | $ | 279,341 | ||||
LIABILITIES
AND STOCKHOLDERS' EQUITY
|
||||||||
Current
liabilities:
|
||||||||
Accounts
payable
|
$ | 6,064 | $ | 5,580 | ||||
Accrued
liabilities
|
35,656 | 38,282 | ||||||
Deferred
revenue
|
19,654 | 16,710 | ||||||
Total
current liabilities
|
61,374 | 60,572 | ||||||
Other
long term liabilities
|
204 | 229 | ||||||
Total
liabilities
|
61,578 | 60,801 | ||||||
Total
stockholders' equity
|
227,699 | 218,540 | ||||||
Total
liabilities and stockholders' equity
|
$ | 289,277 | $ | 279,341 |
RECONCILIATION
OF GAAP TO NON-GAAP KEY FINANCIAL
METRICS
|
Reconciliation
of GAAP to Non-GAAP Operating Expenses
|
||||||||||||
(in
thousands)
|
||||||||||||
Three
Months Ended
|
||||||||||||
March
31,
2009
|
December
31,
2008
|
March
31,
2008
|
||||||||||
GAAP
Operating expenses
|
$ | 47,423 | $ | 52,567 | $ | 50,542 | ||||||
Restructuring
|
(910 | ) | (4,042 | ) | - | |||||||
Non-GAAP
Operating expenses
|
$ | 46,513 | $ | 48,525 | $ | 50,542 | ||||||
Reconciliation
of GAAP to Non-GAAP Profit from Operations
|
||||||||||||
(in
thousands)
|
||||||||||||
Three
Months Ended
|
||||||||||||
March
31,
2009
|
December
31,
2008
|
March
31,
2008
|
||||||||||
GAAP
Profit from Operations
|
$ | 5,284 | $ | 1,325 | $ | 4,626 | ||||||
Restructuring
|
910 | 4,042 | - | |||||||||
Non-GAAP
Profit from Operations
|
$ | 6,194 | $ | 5,367 | $ | 4,626 | ||||||
Reconciliation
of GAAP to Non-GAAP Net Profit
|
||||||||||||
(in
thousands, except per share amounts)
|
||||||||||||
Three
Months Ended
|
||||||||||||
March
31,
2009
|
December
31,
2008
|
March
31,
2008
|
||||||||||
GAAP
Net profit
|
$ | 2,636 | $ | 65,496 | $ | 5,304 | ||||||
Restructuring
|
910 | 4,042 | - | |||||||||
Tax
effect on non-GAAP adjustments
|
(355 | ) | (43 | ) | - | |||||||
Release
of tax valuation allowance
|
- | (64,608 | ) | - | ||||||||
Non-GAAP
Net profit
|
$ | 3,191 | $ | 4,887 | $ | 5,304 | ||||||
Diluted
Net profit per share:
|
||||||||||||
GAAP
|
$ | 0.04 | $ | 0.98 | $ | 0.07 | ||||||
Non-GAAP
|
$ | 0.05 | $ | 0.07 | $ | 0.07 | ||||||
Shares
used in computing diluted net profit share
|
66,447 | 66,816 | 70,860 |
Q2
2009
|
||||||||||||
GAAP
|
Adjustment
|
(a) |
Non-GAAP
|
|||||||||
Net
Revenue
|
$67.5
- $70.5
|
$67.5
- $70.5
|
||||||||||
Gross
Margin
|
74.5%
- 75.0%
|
74.5%
- 75.0%
|
||||||||||
Operating
Expenses
|
$50.5
-$52.0
|
$ | 0.6 | (a) |
449.9
- $51.4
|
|||||||
Operating
Margin
|
0%
- 1%
|
1 | % |
1%
- 2%
|
||||||||
Net
Income per Diluted Share
|
$0.00
- $0.01
|
$ | 0.01 |
$0.01
- $0.02
|
||||||||
Stock
Based Compensation Expense:
|
||||||||||||
Cost
of Revenues
|
$ | 0.5 | $ | 0.5 | ||||||||
Operating
Expenses
|
$ | 4.4 | $ | 4.4 | ||||||||
Total
Stock Based Compensation Expense
|
$ | 4.9 | $ | 4.9 |
Q2
2009
|
||||
Case
Shipments
|
48.0K - 50.0K | |||
Cash
|
$122M - $126M | |||
DSO
|
mid
60's
|
|||
Capex
|
$2.0M - $4.0M | |||
Depreciation
& Amortization
|
42.0M - $3.0M | |||
Diluted
Shares Outstanding
|
67M | |||
Full
Year 2009:
|
FY
2009
|
|||
Stock
Based compensation
|
$ | 17.5M | ||
Diluted
Shares Outstanding
|
67M |